Eugene Rosenthall, DPM
Podiatrist · Denver, CONPI 1093713265
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,071 of the $2,847 with a category attached, or 72.7%. 12 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 40.4% of the total.
Across 37 payments — averaging $76.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Paragon 28, Inc.$711
- Organogenesis Inc.$313
- Smith+Nephew$279
- Paratek Pharmaceuticals, Inc.$211
- Vaporox, Inc.$38
- plus $146 from 6 others
What the payments were for
- Travel & lodging$77727%
- Food & beverage$2,07173%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 16 | $1,150 |
| Paragon 28, Inc. | 4 | $711 |
| Organogenesis Inc. | 6 | $313 |
| Smith+Nephew | 2 | $279 |
| Paratek Pharmaceuticals, Inc. | 1 | $211 |
| Vaporox, Inc. | 2 | $38 |
| Mimedx Group, Inc. | 1 | $30 |
| Johnson & Johnson | 1 | $29 |
| Bioventus LLC | 1 | $29 |
| Gemini Mountain Medical, LLC | 1 | $24 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$611
- GRAFIX PL$279
- NUZYRA$211
- PuraPly$125
- NOVACHOR$122
- Affinity$122
- TMC NANOPLASTY SYSTEM$106
How this compares
$2,847 in reported general payments places this provider in the 60th percentile of 70 podiatrist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 23 | $669 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Denver
- Amber KavanaghDenver$20K
- Kenneth MorganDenver$20K
- Andrea BatraDenver$12K
- Varun ChopraDenver$10K
- Eric HillmannDenver$9K
- Kevin NguyenDenver$9K
- Oliver KnauerDenver$7K
- Christopher ScottenDenver$7K
- Olivia AlloreDenver$4K
- Angela TebaldiDenver$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.